EXHIBIT 10.1
EXECUTIVE EMPLOYMENT AGREEMENT
This EXECUTIVE EMPLOYMENT AGREEMENT (the "Agreement") is made as of
February 10, 2003 between Lauren P. Silvernail (the "Executive"), and ISTA
Pharmaceuticals, Inc., a Delaware corporation (the "Company").
WHEREAS, the Company desires to employ Executive and Executive desires
to be employed by the Company, upon the terms and conditions hereinafter set
forth;
NOW, THEREFORE, in consideration of the mutual covenants and obligations
contained herein, and intending to be legally bound, the parties agree as
follows:
1. EMPLOYMENT AND TERM. The Company hereby employs Executive, and
Executive hereby accepts employment with the Company at its offices in Irvine,
California, commencing on March 10, 2003 (the "Effective Date").
2. POSITION AND DUTIES.
(a) CHIEF FINANCIAL OFFICER AND VICE-PRESIDENT CORPORATE
DEVELOPMENT. Executive will hold the office of Chief Financial Officer and VP
Corporate Development of the Company, reporting to the President & Chief
Executive Officer of the Company, serving the Company faithfully and to the best
of her ability, whereby she shall devote her full work time, attention, skill
and efforts to the performance of her duties. Such duties shall be carried out
principally at the Company's headquarters in Irvine, California, and such other
locations upon which Executive and the Board may agree. Executive shall have
such duties and responsibilities as are normal for such position, and will work
in close cooperation with the President and Board of Directors.
3. COMPENSATION. The Company shall pay Executive, and Executive hereby
agrees to accept, as compensation for all services to be rendered to the Company
and for Executive's agreements concerning intellectual property covenants
described by Sections within this Agreement hereof and attachments to this
Agreement, the compensation set forth in this Section 3.
(a) SALARY. Beginning on the Effective Date, the Company shall
pay Executive an initial gross monthly base salary of Seventeen Thousand
Eighty-Three Dollars and Thirty-Three Cents ($17,083.33), which reflects an
annualized salary amount of Two Hundred and Five Thousand Dollars ($205,000).
The Salary shall be inclusive of all applicable income, social security and
other taxes and charges that are required by law to be withheld by the Company
and shall be paid and withheld in accordance with the Company's normal payroll
practices for its executive employees. The Company may in its discretion adjust
this salary from time to time in the future.
(b) STOCK OPTIONS.
(i) Upon the Effective Date of this Agreement, Executive
will be granted a stock option to purchase 165,000 shares of the Company's
Common Stock in
accordance with the terms of the 2000 Stock Plan, as amended. The exercise price
for the Shares shall be the fair market value of the Company's Common Stock at
the time of grant (the "Option"). The Option will vest as to 25% of the shares
subject to the Option on the one-year anniversary of the Effective Date, and as
to 1/48th of the shares subject to the Option monthly thereafter, so that the
Option will be fully vested and exercisable on the fourth anniversary of the
Effective Date.
(c) REIMBURSEMENT OF EXPENSES. During the course of employment,
Executive shall be reimbursed for items of travel, food and lodging and
miscellaneous expenses reasonably incurred by her on behalf of the Company,
provided that such expenses are incurred, documented and submitted to the
Company, all in accordance with the reimbursement policies of the Company in
effect at the time the expenses were incurred.
(d) BONUS. Executive shall be eligible to earn an annual
performance bonus of up to 35% of her Salary upon the completion of performance
goals established by the President. Executive shall be eligible for
consideration for a full year bonus in 2003 notwithstanding her employment
commencement date.
(e) COMPANY BENEFITS. While employed by the Company, Executive
shall be entitled to receive the benefits of employment described in the
Company's Employee Handbook, when and as Executive becomes eligible for them.
The Company's Employee Handbook may be revised from time to time at the sole
discretion of the Company. Executive will be eligible to participate in the
company's medical, dental and vision insurance plans, pursuant to their terms.
Additionally, the Company will pay for the costs of short-term, long-term
disability, life insurance and long-term care insurance policies for the benefit
of the Executive as available and at a level consistent with that received by
other employees in comparable positions. Executive will also be entitled to a
total of $5,000 per year for out-of-pocket expenses incurred by Executive,
Executive's spouse and/or minor children for medical, dental, vision or life,
long-term care or disability insurance. Executive will be entitled to four weeks
paid vacation per year.
4. PROPRIETARY INFORMATION AND INVENTIONS AND AGREEMENT. Executive
agrees to enter into and be bound by the provisions of the Company's Employee
Confidentiality and Invention Assignment Agreement (the "Confidentiality
Agreement"), attached hereto as Exhibit A. Notwithstanding any termination of
this Agreement or Executive's employment by the Company, Executive agrees to
continue to be bound by the Confidentiality Agreement. Executive agrees to
comply with any and all current and future Company policies governing employees
generally, and to execute and be bound by any future agreements required of
executives, as a condition of employment, by the Board.
5. OUTSIDE ACTIVITIES.
(a) OTHER EMPLOYMENT. Except with the prior written consent of
the President or as set forth above, Executive will not serve on any other
company's Board of Directors or undertake or engage in any other employment,
occupation or business enterprise, other than ones in which Executive is a
passive investor. Executive may engage in civic and not-for-profit activities so
long as such activities do not materially interfere with the performance of her
duties hereunder.
2
(b) PROFESSIONAL ACTIVITIES. Executive from time to time may
engage in certain professional activities including seminars, speaking
engagements, and authoring of publications so long as such activities do not
materially interfere with the performance of her duties hereunder. Whenever
possible, Executive's expenses should be reimbursed by the other party.
Executive may retain all honoraria or payments received from such activities
only if the Company is not required to reimburse Executive for any expenses
incurred by such activities.
(c) CONFLICT OF INTEREST. While employed by the Company,
Executive shall not engage in any activity in competition with or against the
best interest of the Company and agrees to inform the Company immediately of any
actual or potential conflict of interest as required in the Proprietary
Agreement. This shall include assuming or maintaining any outside business
relationship that might inhibit or prejudice the exercise of sound ethical
judgment or that might otherwise adversely affect the Company or its reputation,
including but not limited to: (i) employment or providing services with another
firm while in the employment of the Company if the firm is a competitor, a
supplier, or one that will likely become a competitor or supplier in the future,
(ii) holding a substantial financial interest in a firm to which the Company
makes sales, or that provides services, materials or equipment to the Company,
and (iii) the acceptance of gifts or favors from an outside organization that
are substantial enough to cause undue influence in conducting business for the
Company.
6. AT WILL EMPLOYMENT. The Company and the Employee acknowledge that the
Employee's employment is and shall continue to be at will at all times during
Employee's employment, which means that either the Employee or the Company can
terminate the employment relationship at any time, with or without cause, and
with or without advance notice. If Employee's at will employment terminates for
any reason, the Employee shall not be entitled to any payments, benefits,
damages, awards or compensation other than as provided by this Agreement or by
the Employee's Change of Control Severance Agreement.
7. TERMINATION. Upon termination of Executive's employment hereunder,
Executive shall be entitled to such compensation and benefits as described in
this Section.
(a) INVOLUNTARY TERMINATION PRIOR TO A CHANGE OF CONTROL. If
Executive's employment with the Company terminates prior to a "Change of
Control" (as defined herein) other than voluntarily or for "Cause" (as defined
herein), and Executive signs and does not revoke a standard release of claims
with the Company, then, subject to Section 9, Executive shall be entitled to
receive continuing payments of severance pay (less applicable withholding taxes)
at a rate equal to her Salary, as then in effect, for a period of six (6) months
from the date of such termination, to be paid periodically in accordance with
the Company's normal payroll policies.
(b) VOLUNTARY TERMINATION; TERMINATION FOR CAUSE. If Executive's
employment with the Company terminates voluntarily by Executive or for Cause by
the Company, then all vesting of the Option will terminate immediately and all
payments of compensation by the Company to Executive hereunder will terminate
immediately, except as to amounts already earned.
(c) DISABILITY. In the event that Executive, because of
accident, disability or physical or mental illness, is incapable of performing
her usual duties hereunder, the Company
3
shall have the right to terminate Executive's employment hereunder upon thirty
(30) days prior written notice to Executive. For purposes of this Section (d),
Executive shall be deemed to have become incapable of performing her usual
duties hereunder if the Board shall reasonably determine that Executive is, by
reason of any medically-determinable physical or mental impairment expected to
result in death or to be of a duration of not less than six (6) months, unable
to perform consistently and materially her usual duties for the Company with or
without reasonable accommodation. If Executive's employment hereunder is
terminated pursuant to this section, the Company shall pay to Executive as her
sole and exclusive right and remedy under this Agreement all accrued and unpaid
base salary and reimbursements through the date of Executive's termination and
Executive shall also be entitled to receive any then accrued stock pursuant to
her stock option agreement, insurance and other rights and benefits to the
extent, if at all, Executive was entitled to them under their respective terms.
8. CHANGE OF CONTROL BENEFITS.
(a) VESTING ACCELERATION AFTER CHANGE OF CONTROL. Executive
shall participate in accelerated vesting after a Change in Control pursuant to
the terms outlined in the Change of Control Severance Agreement attached hereto
as Exhibit B.
(b) SEVERANCE AFTER A CHANGE OF CONTROL. Executive shall be
eligible for severance after a Change in Control pursuant to the terms outlined
in the Change of Control Severance Agreement attached hereto as Exhibit B.
9. DEFINITIONS.
(a) CAUSE. For purposes of this Agreement, "Cause" shall mean:
(i) any breach by Executive concerning confidential or proprietary information
or conflict of interest as detailed by Sections within this Agreement or in the
Proprietary Agreement, (ii) gross breach of fiduciary duty, (iii) material
dishonesty, misrepresentation or theft, (iv) conviction of a crime involving
moral turpitude, or (v) breach of any other material obligations under this
Agreement, which breach has not been cured within thirty (30) days of written
notice by the Company to Executive.
(b) CHANGE OF CONTROL. For purposes of this Agreement, "Change
of Control" shall be defined as that term is defined in Section 1(b) of the
Change of Control Severance Agreement attached hereto as Exhibit B.
10. MISCELLANEOUS.
(a) SURVIVAL OF PROVISIONS. The provisions of this Agreement set
forth by Sections within this Agreement hereof shall survive the termination of
Executive's employment hereunder.
(b) SUCCESSOR AND ASSIGNS. This Agreement shall insure to the
benefit of and be binding upon the Company and Executive and their respective
successors, executors, administrators, heirs, and or assigns; provided that
neither party shall make any assignments of the Agreement or any interest
herein, by operation of law or otherwise, without the prior written
4
consent of the other party, except that the Company may assign its rights and
obligations under this Agreement to a successor or affiliate of the Company
without such consent.
(c) NOTICES. Any notice hereunder by either party shall be given
by personal delivery or by sending such notice by certified mail, or telecopied
to the other party at its address set forth below or at such other address
designated by notice in the manner provided in this section. Such notice shall
be deemed to have been received upon the date of actual delivery if personally
delivered or, in the case of mailing in two business days after deposit with the
US mail, or in the case of facsimile transmission, during the business day when
confirmed by the facsimile machine report or the next business day if received
after normal business hours by the recipient.
(i) If to the Company, to:
Vicente Anido, Jr., Ph.D.
ISTA Pharmaceuticals, Inc.
15279 Alton Parkway, Bldg. 100
Irvine, CA 92618
(ii) If to Executive, to:
Lauren P. Silvernail
10 Hertford Street
Newport Coast, CA 92657-1077
(d) ENTIRE AGREEMENT; ATTACHMENTS. This Agreement, including the
Change of Control Severance Agreement, the Confidentiality Agreement and any
outstanding stock option agreements and restricted stock purchase agreements
referenced herein, represent the entire agreement and understanding of the
parties hereto relating to the subject matter hereof and supersedes all prior
and contemporaneous discussions, agreements and understandings of every nature
between the parties hereto relating to the subject matter hereof. This Agreement
may not be changed or modified, except by an agreement in writing signed by each
of the parties hereto.
(e) WAIVER. The waiver of the breach of any term or provision of
this Agreement shall not operate as or be construed to be a waiver of any other
or subsequent breach of this Agreement.
(f) GOVERNING LAW. This Agreement shall be construed and
enforced in accordance with laws of California.
(g) SEVERABILITY. Whenever possible, each provision of the
Agreement will be interpreted in such manner as to be effective and valid under
applicable law, but if any provision of this Agreement is held to be invalid,
illegal, or unenforceable, in any respect under any applicable law or rule in
any jurisdiction, such invalidity, illegality or unenforceability will not
affect any other provision or any other jurisdiction, but this Agreement will be
reformed,
5
construed and enforced in such jurisdiction as closely as possible to conform to
the intentions of the parties.
(h) SECTION HEADINGS. The section headings in this Agreement are
for convenience only; they form no part of this Agreement and shall not affect
its interpretation.
IN WITNESS WHEREOF, parties have caused this Executive Employment
Agreement to be executed the day and year first written above.
ISTA PHARMACEUTICALS, INC.
/s/ Vicente Anido, Jr. Ph.D.
----------------------------------------
Vicente Anido, Jr., Ph.D.
President & Chief Executive Officer
EXECUTIVE
/s/ Lauren P. Silvernail
----------------------------------------
Lauren P. Silvernail
6